Dr. Reddy’s rituximab biosimilar has already been approved for marketing in India and over 25 emerging markets.
Dr. Reddy’s rituximab biosimilar has already been approved for marketing in India and over 25 emerging markets. Dr. Reddy’s rituximab biosimilar has already been approved for marketing in India and over 25 emerging markets. Moneycontrol Latest News Read More